₨ 6,000
Onco-BCG (Bacillus Calmette-Guérin) is a type of immunotherapy drug used to treat early-stage bladder cancer. It is manufactured by the pharmaceutical company Cipla.
Product Details
- Active Ingredient: Lyophilized (freeze-dried) powder of the Bacillus Calmette-Guérin (BCG) strain (40mg).
- Purpose: Treatment and prevention of recurrence of non-muscle-invasive bladder cancer (NMIBC).
- Administration: It is administered by a healthcare professional directly into the bladder using a catheter (intravesical instillation). It is for single use only and not for general immunization.
- Mechanism: The drug stimulates a localized immune response in the bladder lining, causing immune cells to attack and destroy cancer cells.
- Availability: The product is widely available through various medical suppliers and online pharmacies in specific regions.
Important Safety Information
- This medication should only be administered under medical supervision.
- Common side effects include frequent and painful urination, fever, and flu-like symptoms, which typically subside within a few days.
- The live bacteria in the product can be contagious, so specific precautions must be followed for the first several hours after treatment to avoid spreading the bacteria to others.
- It is contraindicated for individuals with weakened immune systems, during pregnancy, or while breastfeeding.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Please consult a healthcare professional for any medical concerns or before starting any new treatment.
₨ 10,000
